Table 1 Laboratory data and lipid profile at six months after transplantation

Hematology

Triglyceride (mg/dL)

685

40–234

 WBC (/μL)

6390

Total cholesterol (mg/dL)

222

142–248

 Hb (g/dL)

11.0

LDL cholesterol (mg/dL)

90.6

65–163

 Platelets (/μL)

25.3

HDL cholesterol (mg/dL)

33.0

38–90

Serum chemistry

Apo A-I (mg/dl)

106

119–155

 AST (IU/L)

21

Apo A-II (mg/dl)

21.3

25.9–35.7

 ALT (IU/L)

14

Apo B (mg/dl)

110

73–109

 Bilirubin (IU/L)

0.4

Apo C-II (mg/dl)

12.9

1.8–4.6

LDH (IU/L)

174

Apo C-III (mg/dl)

24.2

5.8–10.0

Ferritin (ng/ml)

376.8

Apo E (mg/dl)

9.9

2.7–4.3

HbA1c (%)

7.5

Lipoprotein fraction (%)

TP (g/dL)

7.8

α

15.8

26.9–50.5

Alb (g/dL)

3.9

Pre-β

43.2

7.9–23.8

Creatinine (mg/dL)

1.12

Β

30.1

35.3–55.5

CRP (mg/dL)

1.13

CETP (mg/dL)

162

90–200

Proteinuria (g/gCre)

3.77

E/T ratio (%)

68

73–77

sIL-2R (U/ml)

(reference range 184–486)

500

Sd LDL (mg/dL)

47.8

9.5–42.5

LPL activity

25

164–284

Viral tests

 EBV VCA IgM (EIA) (reference range < 0.5)

0.5 ( ±)

 EBV VCA IgG (EIA) (reference range < 0.5)

0.5 ( +)

 EBV EBNA IgG (EIA) (reference range < 0.5)

0.5 ( +)

 CMV IgM (EIA) (reference range < 0.85)

0.73 (˗)

 CMV IgG (EIA) (reference range < 6.0)

8.6 ( +)

 C7-HRP (reference range: negative)

Negative

 Parvovirus B19 IgM (EIA) (reference range < 0.8)

0.31 (˗)